Upregulated NNMT sustains angiogenesis in clear cell renal cell carcinoma through activation of the SDF-1/CXCR4-ERK-CCL20 axis

NNMT 上调通过激活 SDF-1/CXCR4-ERK-CCL20 轴维持透明细胞肾细胞癌中的血管生成。

阅读:1

Abstract

BACKGROUND: Nicotinamide N-methyltransferase (NNMT) is involved in the development of several cancers. Tumor stem cells are present in various cancers and are linked to treatment resistance, tumor recurrence, and metastasis. However, the role of NNMT in regulating the stemness characteristics of clear cell renal cell carcinoma (ccRCC) is not yet fully understood. METHODS: NNMT expression was identified as differentially expressed through the analysis of TCGA and GEO datasets (GSE105261 and GSE66272). Functional significance was explored using xenograft models. We performed qPCR, western blot, enzyme-linked immunosorbent assay (ELISA) and additional assays to examine the effects of NNMT on ccRCC stem cells. The potential molecular mechanism of ccRCC stem cells in promoting angiogenesis was investigated through RNA-seq analysis. The expression of C-C motif chemokine ligand 20 (CCL20) was validated through western blot and ELISA analyses. Regulation of angiogenesis was assessed using tube formation assays and Matrigel plug assays. RESULTS: NNMT was significantly upregulated in ccRCC tumor tissues and impaired the prognosis in ccRCC patients. In vivo studies revealed that NNMT depletion significantly inhibited tumor growth, whereas increased NNMT levels enhanced tumor progression. Additionally, NNMT enhanced the stemness characteristics of ccRCC cells and maintained C-X-C chemokine receptor type 4 (CXCR4) expression through the activation of Signal Transducer and Activator of Transcription 3 (STAT3) phosphorylation. Moreover, NNMT facilitated the recruitment and differentiation of ccRCC stem cells towards endothelial cells via the stromal cell–derived factor 1 (SDF-1)/CXCR4 axis, thereby promoting vessel function and tumor growth. CONCLUSION: NNMT functions as an oncogene, strengthening the stemness properties of ccRCC cells and sustaining angiogenesis. These results indicate that NNMT may be a viable therapeutic target and prognostic biomarker for ccRCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13402-025-01115-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。